U.S. pharma huge copyright scrapped two experimental weight loss pills past yr—a once-day by day tablet, lotiglipron, due to elevated liver enzymes plus a 2 times-every day pill, danuglipron, on account of solid Unwanted side effects—but CEO Albert Bourla has reported the company is